Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
In recent years, several associations between common chronic human disorders and altered gut microbiome composition and function have been reported. In most of these reports, treatment regimens were not controlled for and conclusions could thus be confounded by the effects of various drugs on the microbiota, which may obscure microbial causes, protective factors or diagnostically relevant signals. Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). Two previous quantitative gut metagenomics studies of T2D patients that were unstratified for treatment yielded divergent conclusions regarding its associated gut microbial dysbiosis. Here we show, using 784 available human gut metagenomes, how antidiabetic medication confounds these results, and analyse in detail the effects of the most widely used antidiabetic drug metformin. We provide support for microbial mediation of the therapeutic effects of metformin through short-chain fatty acid production, as well as for potential microbiota-mediated mechanisms behind known intestinal adverse effects in the form of a relative increase in abundance of Escherichia species. Controlling for metformin treatment, we report a unified signature of gut microbiome shifts in T2D with a depletion of butyrate-producing taxa. These in turn cause functional microbiome shifts, in part alleviated by metformin-induced changes. Overall, the present study emphasizes the need to disentangle gut microbiota signatures of specific human diseases from those of medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“patient treatment with the drug metformin, a variable that subjects had not been stratified for previously, constituted the main determinant of microbial signatures in diabetic cohorts [62].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [62]
In the citing paper
“This action is an important determinant for the anti-hyperglycemic therapeutic effects, the gastrointestinal side effects and possibly the anti-aging effects of metformin (88, 89).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“As for C. elegans, metformin use in humans will change the microbiome.”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“Studies comparing individuals with T2D treated or not with metformin identified a higher level of E. coli and a lower level of Intestinibacter in the metformin-treated individuals, while confirming reduced levels of butyrate-producing bacteria such as Roseburia spp., F. prausnitzii, and unnamed Clostridiales in the untreated individuals compared to healthy controls5, 6, 34, 35.”
From The gut microbiome in atherosclerotic cardiovascular disease (2017) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
FLASH: fast length adjustment of short reads to improve genome assemblies
Magoč, T., & Salzberg, S. L. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr507 · Cited by 15,366
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
VEGAN, a package of R functions for community ecology
Dixon, P. (2003) · Journal of Vegetation Science · doi:10.1111/j.1654-1103.2003.tb02228.x · Cited by 6,824
Cited by
Items 501–600 of 1,006
The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais
Sobhonslidsuk, A., Chanprasertyothin, S., Pongrujikorn, T., Kaewduang, P., Promson, K., Petraksa, S., & Ongphiphadhanakul, B. (2018) · BioMed Research International · doi:10.1155/2018/9340316 · Cited by 85
Interaction between gut microbiota and ethnomedicine constituents
Wu, X., & Tan, R. X. (2019) · Natural Product Reports · doi:10.1039/c8np00041g · Cited by 86
Crosstalk between gut microbiota and antidiabetic drug action
Kyriachenko, Y., Falalyeyeva, T. M., Korotkyi, O., Molochek, N., & Kobyliak, N. M. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i3.154 · Cited by 85
Luo, J., Chai, Y., Zhao, M., Guo, Q., & Bao, Y. (2020) · Food & Function · doi:10.1039/d0fo00428f · Cited by 85
Gut Microbiota in NSAID Enteropathy: New Insights From Inside
Wang, X., Tang, Q., Hou, H., Zhang, W., Li, M., Chen, D., Gu, Y., Wang, B., Hou, J., Liu, Y., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.679396 · Cited by 86
MVP: a microbe–phage interaction database
Gao, N., Zhang, C., Zhang, Z., Hu, S., Lercher, M. J., Zhao, X., Bork, P., Liu, Z., & Chen, W.-H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1124 · Cited by 86
Self-citationThe hunt for a healthy microbiome
Eisenstein, M. (2020) · Nature · doi:10.1038/d41586-020-00193-3 · Cited by 84
Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids
Sansome, D. J., Xie, C., Veedfald, S., Horowitz, M., Rayner, C. K., & Wu, T. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13869 · Cited by 84
Bataineh, M. T. A., Dash, N. R., Lassen, P. B., Banimfreg, B. H., Nada, A. M., Belda, E., & Clément, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-66598-2 · Cited by 84
Umirah, F., Neoh, C. F., Ramasamy, K., & Lim, S. M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108689 · Cited by 84
Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics
Guillen, M. N., Li, C. G., Rosener, B., & Mitchell, A. (2024) · Science · doi:10.1126/science.adk7368 · Cited by 84
Understanding the action mechanisms of metformin in the gastrointestinal tract
Cheng, M., Ren, L., Jia, X., Wang, J., & Cong, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1347047 · Cited by 85
Self-citationYu, D., Shu, X., Rivera, E. S., Zhang, X., Cai, Q., Calcutt, M. W., Xiang, Y., Li, H., Gao, Y., Wang, T. J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010606 · Cited by 85
Human Gut Antibiotic Resistome and Progression of Diabetes
Shuai, M., Zhang, G., Zeng, F., Fu, Y., Liang, X., Yuan, L., Xu, F., Gou, W., Miao, Z., Jiang, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202104965 · Cited by 83
Self-citationMetformin acts in the gut and induces gut-liver crosstalk
Tobar, N., Rocha, G. Z., Santos, A., Guadagnini, D., Assalin, H. B., de Camargo, J. A., Gonçalves, A. E. S. S., Pallis, F. R., Oliveira, A. G., Rocco, S. A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211933120 · Cited by 83
Froldi, G. (2024) · Pharmaceuticals · doi:10.3390/ph17040478 · Cited by 83
Endogenous ethanol production in health and disease
Meijnikman, A. S., Nieuwdorp, M., & Schnabl, B. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00937-w · Cited by 83
Liang, Y., Liu, C., Cheng, M., Geng, L., Li, J., Du, W., Song, M., Chen, N., Yeleen, T. A. N., Li, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14057 · Cited by 83
Self-citationRedan, B. W., Buhman, K. K., Novotny, J. A., & Ferruzzi, M. G. (2016) · Advances in Nutrition · doi:10.3945/an.116.013029 · Cited by 83
Vogtmann, E., Han, Y., Caporaso, J. G., Bokulich, N., Mohamadkhani, A., Moayyedkazemi, A., Hua, X., Kamangar, F., Wan, Y., Suman, S., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2660 · Cited by 73
Liu, S., Zhao, W., Liu, X., & Cheng, L. (2020) · The FASEB Journal · doi:10.1096/fj.202000622r · Cited by 84
An investigation into physical frailty as a link between the gut microbiome and cognitive health
Verdi, S., Jackson, M. A., Beaumont, M., Bowyer, R. C. E., Bell, J. T., Spector, T. D., & Steves, C. J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00398 · Cited by 82
Comparison of Fecal Collection Methods for Microbiota Studies in Bangladesh
Vogtmann, E., Chen, J., Kibriya, M. G., Chen, Y., Islam, T., Eunes, M., Ahmed, A., Naher, J., Rahman, A., Amir, A., et al. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.00361-17 · Cited by 81
The oral microbiome profile and biomarker in Chinese type 2 diabetes mellitus patients
Chen, B., Wang, Z., Wang, J., Su, X., Yang, J., Zhang, Q., & Zhang, L. (2020) · Endocrine · doi:10.1007/s12020-020-02269-6 · Cited by 82
Self-citationBioavailability Based on the Gut Microbiota: a New Perspective
Zhang, F., He, F., Li, L., Guo, L., Zhang, B., Yu, S., & Zhao, W. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00072-19 · Cited by 82
Fianchi, F., Liguori, A., Gasbarrini, A., Grieco, A., & Miele, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126485 · Cited by 83
Li, M., Liu, J., Zhu, J., Wang, H., Sun, C., Gao, N. L., Zhao, X.-M., & Chen, W.-H. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2205386 · Cited by 66
Gut Microbiota and Coronary Artery Disease
Yamashita, T., Emoto, T., Sasaki, N., & Hirata, K. (2016) · International Heart Journal · doi:10.1536/ihj.16-414 · Cited by 83
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
Petakh, P., Oksenych, V., & Kamyshnyi, O. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114892 · Cited by 81
Yu, Y., Ding, Y., Wang, S., & Jiang, L. (2025) · Metabolites · doi:10.3390/metabo15060397 · Cited by 81
Cockburn, D. W., Suh, C. E., Medina, K. M. P., Duvall, R., Wawrzak, Z., Henrissat, B., & Koropatkin, N. M. (2017) · Molecular Microbiology · doi:10.1111/mmi.13881 · Cited by 81
Toxicological safety evaluation of pasteurized Akkermansia muciniphila
Druart, C., Plovier, H., Van Hul, M., Brient, A., Phipps, K. R., de Vos, W. M., & Cani, P. D. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4044 · Cited by 68
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Galal, M. A., Al-Rimawi, M., Hajeer, A., Dahman, H., Alouch, S. S., & Aljada, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074083 · Cited by 81
Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome
Singh, A., Cresci, G., & Kirby, D. F. (2018) · Nutrition in Clinical Practice · doi:10.1002/ncp.10181 · Cited by 80
Zhang, C., Ma, S., Wu, J., Luo, L., Qiao, S., Li, R., Xu, W., Wang, N., Zhao, B., Wang, X. D., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104985 · Cited by 79
Saber, S., & El-Kader, E. M. A. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00730-6 · Cited by 79
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Degraeve, A. L., Haufroid, V., Loriot, A. E., Gatto, L., Andries, V., Vereecke, L., Elens, L., & Bindels, L. B. (2023) · Microbiome · doi:10.1186/s40168-023-01578-y · Cited by 79
The Human Mucosal Mycobiome and Fungal Community Interactions
Witherden, E. A., Shoaie, S., Hall, R. A., & Moyes, D. L. (2017) · Journal of Fungi · doi:10.3390/jof3040056 · Cited by 79
Devi, T. B., Devadas, K., George, M., Gandhimathi, A., Chouhan, D., Retnakumar, R. J., Alexander, S. M., Varghese, J., Dharmaseelan, S., Chandrika, S. K., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.631140 · Cited by 78
Chen, J., Wang, A., & Wang, Q. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04199-0 · Cited by 78
Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery
Zhou, K., Pedersen, H., Dawed, A. Y., & Pearson, E. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.51 · Cited by 78
Involvement of glucagon‐like peptide‐1 in the glucose‐lowering effect of metformin
Bahne, E., Hansen, M., Brønden, A., Sonne, D. P., Vilsbøll, T., & Knop, F. K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12697 · Cited by 72
Gonai, M., Shigehisa, A., Kigawa, I., Kurasaki, K., Chonan, O., Matsuki, T., Yoshida, Y., Aida, M., Hamano, K., & Terauchi, Y. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0230 · Cited by 78
The human microbiome in health and disease: hype or hope
Falony, G., Vandeputte, D., Caenepeel, C., Vieira‐Silva, S., Daryoush, T., Vermeire, S., & Raes, J. (2019) · Acta Clinica Belgica · doi:10.1080/17843286.2019.1583782 · Cited by 79
Self-citationManiar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 77
Benedetti, R., Benincasa, G., Glass, K., Chianese, U., Vietri, M. T., Congi, R., Altucci, L., & Napoli, C. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106039 · Cited by 77
Liu, W., Luo, Z., Zhou, J., & Sun, B. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.853771 · Cited by 78
Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis
Zhang, E., Jin, L., Wang, Y., Tu, J., Zheng, R., Ding, L., Fang, Z., Fan, M., Al-Abdullah, I., Natarajan, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28743-5 · Cited by 76
Human Gut Microbiota in Health and Selected Cancers
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413440 · Cited by 77
Modulation effect of tea consumption on gut microbiota
Liu, Y., Li, X., & Shen, L. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10306-2 · Cited by 75
Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes
Patra, D., Banerjee, D., Ramprasad, P., Roy, S., Pal, D., & Dasgupta, S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1224982 · Cited by 77
Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes
Mardinoğlu, A., Borén, J., & Smith, U. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.012 · Cited by 75
A proinflammatory CD4+ T cell phenotype in gestational diabetes mellitus
Sheu, A., Chan, Y., Ferguson, A. L., Bakhtyari, M. B., Hawke, W., White, C., Chan, Y. F., Bertolino, P., Woon, H. G., Palendira, U., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4615-1 · Cited by 76
Quantifying technical confounders in microbiome studies
Bartolomaeus, T. U. P., Birkner, T., Bartolomaeus, H., Löber, U., Avery, E. G., Mähler, A., Weber, D., Kochlik, B., Balogh, A., Wilck, N., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa128 · Cited by 75
Characteristics of the gut microbiome in patients with prediabetes and type 2 diabetes
Zhang, Z., Tian, T., Chen, Z., Liu, L., Luo, T., & Dai, J. (2021) · PeerJ · doi:10.7717/peerj.10952 · Cited by 74
Microbe-based therapies for colorectal cancer: Advantages and limitations
Saeed, M., Shoaib, A., Kandimalla, R., Javed, S., Almatroudi, A., Gupta, R. C., & Aqil, F. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.018 · Cited by 74
Tousoulis, D., Guzik, T. J., Padró, T., Duncker, D. J., Luca, G. D., Eringa, E. C., Vavlukis, M., Antonopoulos, A. S., Katsimichas, T., Cenko, E., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac057 · Cited by 75
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Heinzel, S., Aho, V. T. E., Suenkel, U., von Thaler, A., Schulte, C., Deuschle, C., Paulin, L., Hantunen, S., Brockmann, K., Eschweiler, G. W., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26128 · Cited by 68
The Anti-Aging Mechanism of Metformin: From Molecular Insights to Clinical Applications
Zhang, T., Li-jun, Z., Makarczyk, M. J., Feng, P., & Zhang, J. (2025) · Molecules · doi:10.3390/molecules30040816 · Cited by 74
From taxonomy to metabolic output: what factors define gut microbiome health?
Wilmanski, T., Rappaport, N., Diener, C., Gibbons, S. M., & Price, N. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907270 · Cited by 73
Targeting glucose metabolism for healthy aging
Brewer, R. A., Gibbs, V. K., & Smith, D. L. (2016) · Nutrition and Healthy Aging · doi:10.3233/nha-160007 · Cited by 68
Gowd, V., Xie, L., Zheng, X., & Chen, W. (2019) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2019.1576025 · Cited by 73
Ponziani, F. R., Nicoletti, A., Gasbarrini, A., & Pompili, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919848184 · Cited by 69
Jergens, A. E., Guard, B. C., Redfern, A., Rossi, G., Mochel, J. P., Pilla, R., Chandra, L. C., Seo, Y., Steiner, J. M., Lidbury, J. A., et al. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00199 · Cited by 73
Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Chatelier, E. L., Sunagawa, S., Prifti, E., Vieira‐Silva, S., Guðmundsdóttir, V., Pedersen, H., et al. (2017) · Nature · doi:10.1038/nature22318 · Cited by 73
Self-citationGut cell metabolism shapes the microbiome
Cani, P. D. (2017) · Science · doi:10.1126/science.aao2202 · Cited by 66
Genetic Pathways of Aging and Their Relevance in the Dog as a Natural Model of Human Aging
Sándor, S., & Kubinyi, E. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00948 · Cited by 72
Ang, Q. Y., Alba, D., Upadhyay, V., Bisanz, J. E., Cai, J., Lee, H. L., Barajas, E., Wei, G., Noecker, C. A., Patterson, A. D., et al. (2021) · eLife · doi:10.7554/elife.70349 · Cited by 72
Gut Microbiota Composition and Fecal Metabolic Profiling in Patients With Diabetic Retinopathy
Zhou, Z., Zheng, Z., Xiong, X., Chen, X., Peng, J., Yao, H., Pu, J., Chen, Q., & Zheng, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732204 · Cited by 72
Chen, S., Chen, L., Qi, Y., Xu, J., Ge, Q., Fan, Y., Chen, D., Zhang, Y., Wang, L., Hou, T., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00129-0 · Cited by 72
Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses
Wu, H., Norton, V., Cui, K., Zhu, B., Bhattacharjee, S., Lu, Y. W., Wang, B., Shan, D., Wong, S., Dong, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.841928 · Cited by 72
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 72
Paul, P., Kaul, R., Harfouche, M., Arabi, M., Al-Najjar, Y. A., Sarkar, A., Saliba, R., & Châari, A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106520 · Cited by 73
Metformin, Cognitive Function, and Changes in the Gut Microbiome
Rosell-Díaz, M., & Fernández‐Real, J. M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad029 · Cited by 72
Giannoudaki, E., Hernandez-Santana, Y., Mulfaul, K., Doyle, S., Hams, E., Fallon, P. G., Mat, A., O'Shea, D. B., Köpf, M., Hogan, A. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11944-w · Cited by 72
Rettedal, E. A., Cree, J. M. E., Adams, S. E., MacRae, C. L., Skidmore, P. M. L., Cameron‐Smith, D., Gant, N., Blenkiron, C., & Merry, T. L. (2020) · Experimental Physiology · doi:10.1113/ep088744 · Cited by 72
Yao, Y., Chen, H., Yan, L., Wang, W., & Wang, D. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110669 · Cited by 71
Integrating the gut microbiome and pharmacology
Verdegaal, A. A., & Goodman, A. L. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg8357 · Cited by 72
Wirbel, J., Essex, M., Forslund, S. K., & Zeller, G. (2024) · Genome biology · doi:10.1186/s13059-024-03390-9 · Cited by 73
Non-antibiotics disrupt colonization resistance against enteropathogens
Grießhammer, A., de la Cuesta‐Zuluaga, J., Müller, P., Gekeler, C., Homolak, J., Chang, H., Schmitt, K., Planker, C., Schmidtchen, V., Gallage, S., et al. (2025) · Nature · doi:10.1038/s41586-025-09217-2 · Cited by 71
The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment
Xu, Y., Zhou, H., & Zhu, Q. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00106 · Cited by 66
Kapur, R., Kim, M. H., Rebetz, J., Hallström, B. M., Björkman, J., Takabe-French, A., Kim, N., Liu, J., Shanmugabhavananthan, S., Milosevic, S., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018018903 · Cited by 71
Factors predictive of high-output ileostomy: a retrospective single-center comparative study
Takeda, M., Takahashi, H., Haraguchi, N., Miyoshi, N., Hata, T., Yamamoto, H., Matsuda, C., Mizushima, T., Doki, Y., & Mori, M. (2018) · Surgery Today · doi:10.1007/s00595-018-1756-2 · Cited by 71
Composition and diversity of gut microbiota in diabetic retinopathy
Bai, J., Wan, Z., Zhang, Y., Wang, T., Xue, Y., & Peng, Q. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.926926 · Cited by 70
“they found decreased abundance of butyrate-producing bacteria in patients with diabetes (Qin et al., 2012; Karlsson et al., 2013; Forslund et al., 2015).”
Publisher Correction: The gut–liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 70
Ejtahed, H., Tavassol, Z. H., Khatami, S., Zangeneh, M., Behrouzi, A., Badi, S. A., Moshiri, A., Hasani‐Ranjbar, S., Soroush, A., Vaziri, F., et al. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00502-7 · Cited by 70
Gut Microbiota Parameters Potentially Useful in Clinical Perspective
Pierro, F. D. (2021) · Microorganisms · doi:10.3390/microorganisms9112402 · Cited by 70
Meta-Analysis Reveals Compositional and Functional Microbial Changes Associated with Osteoporosis
Akinsuyi, O., & Roesch, L. F. W. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00322-23 · Cited by 70
Kragsnæs, M. S., Kjeldsen, J., Horn, H. C., Munk, H. L., Pedersen, F. M., Holt, H. M., Stengaard‐Pedersen, K., Holm, D. K., Glerup, H., Andersen, V. C., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019231 · Cited by 70
Self-citationThe Gut Microbiome, Metformin, and Aging
Induri, S. N. R., Kansara, P., Thomas, S. C., Xu, F., Saxena, D. B., & Li, X. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051920-093829 · Cited by 71
Gershuni, V. M., Li, Y., Elovitz, M. A., Li, H., Wu, G. D., & Compher, C. W. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa361 · Cited by 69
Metformin-induced reductions in tumor growth involves modulation of the gut microbiome
Broadfield, L. A., Saigal, A., Szamosi, J. C., Hammill, J. A., Bezverbnaya, K., Wang, D., Gautam, J., Tsakiridis, E. E., Pastena, F. D., McNicol, J. D., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101498 · Cited by 69
Elbere, I., Silamiķelis, I., Dindune, I. I., Kalniņa, I., Briviba, M., Zaharenko, L., Silamiķele, L., Rovīte, V., Gudrā, D., Konrāde, I., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241338 · Cited by 69
Silamiķele, L., Silamiķelis, I., Ustinova, M., Kalniņa, Z., Elbere, I., Petrovska, R., Kalniņa, I., & Kloviņš, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626359 · Cited by 68
Biofilm-based delivery approaches and specific enrichment strategies of probiotics in the human gut
Gao, J., Sadiq, F. A., Zheng, Y., Zhao, J., He, G., & Sang, Y. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2126274 · Cited by 69
Leveraging premalignant biology for immune-based cancer prevention
Spira, A. E., Disis, M. L., Schiller, J. T., Vilar, E., Rebbeck, T. R., Bejar, R. L., Ideker, T., Arts, J., Yurgelun, M. B. B., Mesirov, J. P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608077113 · Cited by 68
Targeting the Microbiota in Pharmacology of Psychiatric Disorders
Pascale, A., Marchesi, N., Govoni, S., & Barbieri, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104856 · Cited by 67
Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis
Ammer-Herrmenau, C., Antweiler, K. L., Asendorf, T., Beyer, G., Buchholz, S. M., Cameron, S., Capurso, G., Damm, M., Dang, L., Frost, F., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-330987 · Cited by 67
“45 Thus, we carefully collected and factored in multiple known confounding features using a comprehensive approach which was previously applied by our group.”
MethodInflammation in Children with CKD Linked to Gut Dysbiosis and Metabolite Imbalance
Holle, J. B., Bartolomaeus, H., Löber, U., Behrens, F., Bartolomaeus, T. U. P., Anandakumar, H., Wimmer, M. I., Vu, D. L., Kuhring, M., Brüning, U., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022030378 · Cited by 67
Morowitz, M. J., Di Caro, V., Pang, D., Cummings, J., Firek, B., Rogers, M. B., Ranganathan, S., Clark, R. S. B., & Aneja, R. K. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002291 · Cited by 61
Metadata
- Authors
- MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., Arumugam, M., Kristiansen, K., Yvonne Voigt, A., Vestergaard, H., Hercog, R., Igor Costea, P., Roat Kultima, J., Li, J., Jørgensen, T., Levenez, F., Dore, J., Bjørn Nielsen, H., Brunak, S., Raes, J., Hansen, T., Wang, J., Dusko Ehrlich, S., Bork, P., & Pedersen, O.
- Affiliations
- Vrije Universiteit Brussel (BE)
- University of Copenhagen (DK)
- Rega Institute for Medical Research (BE)
- European Molecular Biology Laboratory (DE)
- Microbiologie de l’alimentation au service de la santé (FR)
- BGI Group (China) (CN)
- Corresponding author
- Pedersen, Oluf
- ORCID
- Venue
- Nature
- Published
- 2015-12-02
- Volume
- 528
- Issue
- 7581
- Pages
- 262-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4681099
- OpenAlex
- W2188930066
- Cited by
- 2,116
- References
- 49
- Citations by year
- 2026: 113 · 2025: 167 · 2024: 212 · 2023: 194 · 2022: 253 · 2021: 270 · 2020: 256 · 2019: 185 · 2018: 197 · 2017: 150 · 2016: 112 · 2015: 3
- FWCI
- 66.83
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-05-04)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Innovationsfonden
- European Molecular Biology Laboratory
- European Commission (600375, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, 305312, 201052, 261376)
- Agence Nationale de la Recherche (ANR-11-DPBS-0001)
- Lundbeckfonden
- Novo Nordisk
- Göteborgs Universitet
- Copenhagen Graduate School for Nanoscience and Nanotechnology
- Novo Nordisk Foundation Center for Basic Metabolic Research
- H. Lundbeck A/S
- FP7 Ideas: European Research Council (268985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- type 2 diabetes, gut microbiota, metformin, antidiabetic drugs, dysbiosis, confounding by treatment, short-chain fatty acids, butyrate, Escherichia, metagenome-wide association study
- MeSH terms
- Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Male, Metformin, RNA, Ribosomal, 16S, Biodiversity, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.